IL71598A - Preparation of base salts of piroxicam deposited on a pharmaceutically-acceptable carrier - Google Patents

Preparation of base salts of piroxicam deposited on a pharmaceutically-acceptable carrier

Info

Publication number
IL71598A
IL71598A IL71598A IL7159884A IL71598A IL 71598 A IL71598 A IL 71598A IL 71598 A IL71598 A IL 71598A IL 7159884 A IL7159884 A IL 7159884A IL 71598 A IL71598 A IL 71598A
Authority
IL
Israel
Prior art keywords
piroxicam
pharmaceutically
acceptable carrier
preparation
base salts
Prior art date
Application number
IL71598A
Other languages
English (en)
Other versions
IL71598A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL71598A0 publication Critical patent/IL71598A0/xx
Publication of IL71598A publication Critical patent/IL71598A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
IL71598A 1983-04-25 1984-04-20 Preparation of base salts of piroxicam deposited on a pharmaceutically-acceptable carrier IL71598A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48830383A 1983-04-25 1983-04-25

Publications (2)

Publication Number Publication Date
IL71598A0 IL71598A0 (en) 1984-07-31
IL71598A true IL71598A (en) 1987-01-30

Family

ID=23939186

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71598A IL71598A (en) 1983-04-25 1984-04-20 Preparation of base salts of piroxicam deposited on a pharmaceutically-acceptable carrier

Country Status (28)

Country Link
EP (1) EP0123520B1 (fi)
JP (1) JPS59205375A (fi)
KR (1) KR840008345A (fi)
AT (1) ATE36531T1 (fi)
AU (1) AU548451B2 (fi)
BG (1) BG40810A3 (fi)
CA (1) CA1213220A (fi)
CS (1) CS246078B2 (fi)
DD (1) DD219672A5 (fi)
DE (1) DE3473454D1 (fi)
DK (1) DK165168C (fi)
EG (1) EG17887A (fi)
ES (1) ES8505365A1 (fi)
FI (1) FI82377C (fi)
GR (1) GR81938B (fi)
GT (1) GT198404085A (fi)
HU (1) HU194217B (fi)
IE (1) IE57327B1 (fi)
IL (1) IL71598A (fi)
MX (1) MX159889A (fi)
NO (1) NO165177C (fi)
NZ (1) NZ207930A (fi)
PH (1) PH18864A (fi)
PL (1) PL144064B1 (fi)
PT (1) PT78473B (fi)
RO (1) RO88420A (fi)
YU (1) YU44232B (fi)
ZA (1) ZA843013B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN160683B (fi) * 1981-06-01 1987-07-25 Pfizer
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts

Also Published As

Publication number Publication date
PH18864A (en) 1985-10-21
EP0123520B1 (en) 1988-08-17
PL247378A1 (en) 1985-03-26
IE840982L (en) 1984-10-25
DD219672A5 (de) 1985-03-13
RO88420A (ro) 1986-01-30
NO165177C (no) 1991-01-09
HUT34023A (en) 1985-01-28
EP0123520A1 (en) 1984-10-31
ES531866A0 (es) 1985-05-16
DK165168B (da) 1992-10-19
FI82377B (fi) 1990-11-30
CA1213220A (en) 1986-10-28
DK204484D0 (da) 1984-04-24
JPH0251527B2 (fi) 1990-11-07
NO841611L (no) 1984-10-26
YU44232B (en) 1990-04-30
EG17887A (en) 1991-03-30
KR840008345A (ko) 1984-12-14
ZA843013B (en) 1985-12-24
IL71598A0 (en) 1984-07-31
DE3473454D1 (en) 1988-09-22
NO165177B (no) 1990-10-01
HU194217B (en) 1988-01-28
MX159889A (es) 1989-09-27
BG40810A3 (en) 1987-02-16
GR81938B (fi) 1984-12-12
JPS59205375A (ja) 1984-11-20
FI841604A0 (fi) 1984-04-24
FI841604A (fi) 1984-10-26
PL144064B1 (en) 1988-04-30
DK204484A (da) 1984-10-26
PT78473B (en) 1986-08-28
NZ207930A (en) 1986-09-10
GT198404085A (es) 1985-10-16
ES8505365A1 (es) 1985-05-16
YU72484A (en) 1988-04-30
DK165168C (da) 1993-03-08
PT78473A (en) 1984-05-01
AU548451B2 (en) 1985-12-12
ATE36531T1 (de) 1988-09-15
CS246078B2 (en) 1986-10-16
AU2716084A (en) 1984-11-01
IE57327B1 (en) 1992-07-29
FI82377C (fi) 1991-03-11

Similar Documents

Publication Publication Date Title
EP0003199A3 (en) Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
EG17887A (en) Process for preparing of base salts of piroxicam deposited on a pharmaceutically-acceptable carrier
IT1232303B (it) Composti di diammina e loro sali, procedimenti per la loro preparazio ne e composizioni farmaceutiche contenenti detti composti e i loro sa li
ES8304978A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
EP0100516A3 (en) 3-beta-(3'-(carboxypropionyloxy))-ursa-9(11),12-dience-28-carboxylic acid and its salts, process for its preparation and medicines containing these compounds
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
HUT35519A (en) Process for producing of anelgetic medical preparatives
JPS525755A (en) Process for preparation of 3-amino-4-homotwistane and its acid salts
NZ508467A (en) Sustained release heterodisperse hydrogel systems - amorphous drugs